Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Holders of 5% or more of TPST
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tempest Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Tempest Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Tempest Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 20257:14 PM ET | Versant Venture Capital VI, L.P.and 8 others | 13D/A | 3.70%163.0K shares | −1.10 ppfrom 4.80%Below 5% | Aug 11, 2025 | SEC |
| Feb 11, 20255:58 PM ET | Versant Venture Capital VI, L.P.and 8 others | 13D/A | 4.80%2.12M shares | –Below 5% | Nov 12, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Tempest Therapeutics, Inc. shares.
No Form 144 notices for Tempest Therapeutics, Inc. are on file.